Subscribe to MDT Magazine News

NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development

March 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., March 31, 2011 /- NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited to present the results of a recent QTinno ® performance study at an upcoming conference entitled...


Virtual Radiologic Wins Stevie® Award for Improving Patient Care through Mobile Technology

March 31, 2011 5:33 am | by Bio-Medicine.Org | Comments

EDEN PRAIRIE, Minn., March 31, 2011 /- Virtual Radiologic (vRad), a technology-enabled national radiology practice, was recently awarded the 2011 Stevie® Award for Sales & Customer Service. vRad® Results (SM) is a cloud communication tool, hosted and managed via the...


Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results

March 31, 2011 3:37 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., March 31, 2011 /- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX ), an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and...


Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression

March 31, 2011 3:36 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., March 31, 2011 /- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD).  The trial is expected to begin during the second half of 2011....


Nile Therapeutics Receives Fast Track Designation for Cenderitide for Post-Acute Indication

March 31, 2011 3:35 am | by Bio-Medicine.Org | Comments

SAN MATEO, Calif., March 31, 2011 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Nile's post-acute...


Lilly's Connecting Hearts Abroad Program Sends Employees on Global Service Assignments

March 31, 2011 3:35 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, March 31, 2011 /- Eli Lilly and Company's (NYSE: LLY ) new global service program, Connecting Hearts Abroad, is set to launch. Through the program, the company is sending 200 Lilly Ambassadors to assist people and communities that often lack basic resources. While serving...


Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting

March 31, 2011 3:34 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., March 31, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that data on QNEXA®, its investigational drug candidate, will be featured in a poster presentation at the 60th Annual Scientific Meeting of The American College of Cardiology, being held April 2-5,...


Meeting in Montreal focuses on major issues for children

March 31, 2011 2:38 am | by EurekAlert | Comments

(Society for Research in Child Development) The Society for Research in Child Development will hold its biennial meeting in Montreal, March 31-April 2, 2011, at the Palais des congrès de Montréal. This meeting brings together thousands of leading US and international experts to...


Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering

March 31, 2011 2:36 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., March 31, 2011 /- Patient Safety Technologies, Inc. (the "Company") (OTC Bulletin Board: PSTX ) today announced the closing of a $7.1 million common stock financing.  The investors, led by a new institutional investor, together with several existing shareholders and...


Adeona Reports 2010 Year End Financial Results

March 31, 2011 2:34 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., March 31, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, today reported its financial results for the year ended December 31, 2010, as well as updates since the beginning of the 4th...


Study suggests a relationship between migraine headaches in children and a common heart defect

March 30, 2011 9:31 pm | by EurekAlert | Comments

(Elsevier Health Sciences) Roughly 15% of children suffer from migraines, and approximately one-third of these affected children have migraines with aura, a collection of symptoms that can include weakness, blind spots, and even hallucinations. Although the causes of migraines are...


AP Top News at 12:30 a.m. EDT

March 30, 2011 8:45 pm | by The Associated Press | Comments

Gadhafi's forces adapt to airstrikes, pound rebelsAJDABIYA, Libya (AP) — Moammar Gadhafi's ground forces recaptured a strategic oil town Wednesday and moved within striking distance of another major eastern city, nearly reversing the gains rebels made since international airstrikes began. Rebels...

An Up-Close View of Seizures

March 30, 2011 8:36 pm | by Massachusetts Institute of Technology | Comments

The ability to measure single cells firing in epileptic patients could shed light on how seizures spread.


WiSpry signs far-reaching distribution agreement with EDOM technology

March 30, 2011 7:38 pm | by I-Micronews | Comments

EDOM extends WiSpry?s footprint to crucial Asian markets.

Knowles Acoustics introduces an ultra low-power digital MEMS joystick for handheld consumer devices

March 30, 2011 7:38 pm | by I-Micronews | Comments

Knowles Acoustics announces the introduction of a MEMS joystick which enhances user experience while navigating, scrolling and playing games on handheld devices.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.